The gastrin-releasing peptide receptor (GRPR) is a G-protein coupled receptor overexpressed in a number of cancer types such as prostate cancer, breast cancer, and gastrointestinal cancer, thereby representing an attractive molecule for tumor targeting [1, 2]. This evidence concerns the gene GRPR and breast carcinoma.